RVLP
RVL Pharmaceuticals plc Ordinary Shares
RVLP
RVLP
Delisted
RVLP was delisted on the 20th of October, 2023.
36 hedge funds and large institutions have $27.8M invested in RVL Pharmaceuticals plc Ordinary Shares in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
36
Holders Change
+5
Holders Change %
+16.13%
% of All Funds
0.57%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
9
Reduced
7
Closed
5
Calls
$111K
Puts
$6K
Net Calls
+$105K
Net Calls Change
+$89K
Top Buyers
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$1.05M |
| 2 |
MWM
Marietta Wealth Management
Marietta,
Georgia
|
+$203K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$185K |
| 4 |
BlackRock
New York
|
+$91.6K |
| 5 |
Charles Schwab
San Francisco,
California
|
+$56K |
Top Sellers
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.22M |
| 2 |
Renaissance Technologies
New York
|
-$624K |
| 3 |
Two Sigma Investments
New York
|
-$275K |
| 4 |
Morgan Stanley
New York
|
-$156K |
| 5 |
Two Sigma Advisers
New York
|
-$76.5K |
